Abstract:

Computational modelling has now come of age and is rapidly

emerging as an essential component of the molecular biology toolkit. A

major exciting new development has been the exploration of inhibition of

protein:protein interactions, traditionally an impenetrable area in drug

discovery. Inspired by recent developments in this area we will discuss

how a novel set of  home grown p53-activating molecules are proving to

be new reagents for the exploration of molecular/cellular biology and

appear to hold promise as novel therapeutics.

Please note that Chandra will be available for discussions after (and

possibly before) the seminar. Please let me know if /when you would like

to have a chat with him and I'll book a slot in his schedule.

Welcome!

Nathalie Reuter

MBI & CBU